HIVSTRIVENCT07851077
Social Contact-Based Brief Video Interventions To Reduce Stigma and ImproVe Engagement in HIV Prevention and Care and Mental Health Care for Youth Living With and Vulnerable to HIV
A study testing Brief Videos for HIV Stigma in people with HIV and Mental Health, run by City University of New York, School of Public Health.
Trial summary
HIV stigma, poverty, and racism contribute to high rates of mental health problems and impede treatment for young sexually minoritized men living with and vulnerable to HIV. Intersectional interventions can reduce barriers and promote access to health services, thus preventing poor health outcomes including HIV… Read more about this study
- Who is it for?
- Ages 18 to 30 yearsHealthy volunteers can take part
- Conditions the study is for
- HIV, Mental Health
- What is being tested?
- Brief Videos for HIV Stigma
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 3,900 participants
- Where
- No sites listed yet
- Study dates
- 1 Jan 2028to 1 Jul 2031
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 30 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- YSMM from the New York area aged 18-30 who are either living with HIV or vulnerable to HIV.
Who cannot join
- N/A
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Social Contact-Based Brief Video Interventions To Reduce Stigma and ImproVe Engagement in HIV Prevention and Care and Mental Health Care for Youth Living With and Vulnerable to HIV (STRIVE)
HIV stigma, poverty, and racism contribute to high rates of mental health problems and impede treatment for young sexually minoritized men living with and vulnerable to HIV. Intersectional interventions can reduce barriers and promote access to health services, thus preventing poor health outcomes including HIV transmission related behaviors. The STRIVE intervention will address public and internalized HIV stigma and thus reduce the duration of untreated HIV and mental health problems among young men living with or vulnerable to HIV.
- Conditions
- HIV, Mental Health
- Being tested
- Brief Videos for HIV Stigma
- Keywords
- hiv, mental health, adolescents, social media
- Medical subject headings
- Psychological Well-Being, Acquired Immunodeficiency Syndrome
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Brief Videos for HIV StigmaBehavioural
Intersectionally-tailored brief videos to reduce public and internalized HIV stigma (BVHS)
| Study group | Role | What they receive |
|---|---|---|
| intervention group (BVHS) | Experimental | Participants will receive Brief Videos for HIV Stigma (BVHS) Receives: Behavioral: Brief Videos for HIV Stigma |
| Control | No intervention | Participants will receive videos without BVHS |
What is being measured
The primary outcome is the main question the study is designed to answer.
Percentage of participants who attend an HIV care visit within 30 days after enrollment
Linkage to HIV care is defined as completion of at least one visit with a STRIVE telehealth navigator, within 30 days after enrollment. Visit attendance will be recorded as Yes or No documented by a STRIVE telehealth navigator. The outcome will be reported as the percentage of participants who meet this criterion.
Measured: Within 30 days after enrollment
Percentage of participants who are linked to HIV prevention within 30 days after enrollment
Linkage to HIV prevention is defined as completion of at least one visit with a STRIVE telehealth navigator, within 30 days after enrollment. Visit attendance will be recorded as Yes or No documented by a STRIVE telehealth navigator. The outcome will be reported as the percentage of participants who meet this criterion.
Measured: Within 30 days after enrollment
Secondary outcomes (3)
Percentage of participants who are linked to mental health care
Linkage to mental health care is defined as completion of at least one visit with a STRIVE telehealth navigator, within 30 days after enrollment. Visit attendance will be recorded as Yes or No documented by a STRIVE telehealth navigator. The outcome will be reported as the percentage of participants who meet this criterion.
Measured: Within 30 days after enrollment
brief Berger HIV Stigma scale
The 12-item Brief Berger HIV Stigma Scale is a shortened, validated version of the original 40-item Berger HIV Stigma Scale designed to measure perceived, anticipated, and internalized stigma among people living with HIV (PLWH) while reducing respondent burden. Cumulative scores range from 12 to 48, with higher scores reflecting higher levels of perceived stigma.
Measured: Baseline, immediate post, 30 days post
Attitudes Toward Seeking Professional Psychological Help Scale-Short Form
A 10-item questionnaire used to measure a person's general openness and perspective on getting mental health therapy. Total scores generally range from 0 to 30, with higher scores showing a more positive attitude toward going to therapy.
Measured: Baseline, immediately post, 30 days post
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Oct 2026
- Study start1 Jan 2028 (estimated)
- Primary completion1 Jul 2028 (estimated)
- Study completion1 Jul 2031 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HIVStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Screening
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- We will examine efficacy to increase linkage to HIV prevention and treatment and mental health treatment using BVHS vs an attention control. The purpose of the control videos is to present a generic informative video that provides comparable facts but lacks social components that promote identification and emotional engagement. A randomized controlled trial (RCT) will be utilized, with participants randomly assigned to either the intervention group (BVHS) or a control group.
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 3,900 participants (estimated)
Sponsor and investigators
- Lead sponsor
- City University of New York, School of Public Health
- Sponsor type
- University, hospital or other
- Collaborators
- Columbia University
- Responsible party
- Principal investigator, Philip Kreniske, City University of New York, School of Public Health
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07851077
- Sponsor's protocol ID
- R01MH139432
- Acronym
- STRIVE
- Status last verified
- Sep 2026
- First submitted
- 26 Aug 2026
- Last updated
- 1 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 1 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Social Contact-Based Brief Video Interventions To Reduce Stigma and ImproVe Engagement in HIV Prevention and Care and Mental Health Care for Youth Living With and Vulnerable to HIV (STRIVE)
- ClinicalTrials.gov ID
- NCT07851077
- Acronym / sponsor ID
- STRIVE / R01MH139432
- Conditions
- HIV, Mental Health
- Keywords
- hiv, mental health, adolescents, social media
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 3,900 participants (estimated)
- Lead sponsor
- City University of New York, School of Public HealthUniversity, hospital or other
- Collaborators
- Columbia University
- Study start
- 1 Jan 2028 (estimated)
- Primary completion
- 1 Jul 2028 (estimated)
- Study completion
- 1 Jul 2031 (estimated)
- First posted
- 1 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
HIV stigma, poverty, and racism contribute to high rates of mental health problems and impede treatment for young sexually minoritized men living with and vulnerable to HIV. Intersectional interventions can reduce barriers and promote access to health services, thus preventing poor health outcomes including HIV transmission related behaviors. The STRIVE intervention will address public and internalized HIV stigma and thus reduce the duration of untreated HIV and mental health problems among young men living with or vulnerable to HIV.
Study design
- Primary purpose
- Screening
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
- Model description
- We will examine efficacy to increase linkage to HIV prevention and treatment and mental health treatment using BVHS vs an attention control. The purpose of the control videos is to present a generic informative video that provides comparable facts but lacks social components that promote identification and emotional engagement. A randomized controlled trial (RCT) will be utilized, with participants randomly assigned to either the intervention group (BVHS) or a control group.
| Arm | Type | Receives |
|---|---|---|
| intervention group (BVHS) | Experimental | Behavioral: Brief Videos for HIV StigmaParticipants will receive Brief Videos for HIV Stigma (BVHS) |
| Control | No intervention | –Participants will receive videos without BVHS |
Who may qualify
- Ages
- 18 to 30 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- YSMM from the New York area aged 18-30 who are either living with HIV or vulnerable to HIV.
Key exclusion criteria (1 listed)
- N/A
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Brief Videos for HIV StigmaIntersectionally-tailored brief videos to reduce public and internalized HIV stigma (BVHS) | Behavioural | intervention group (BVHS) |
Primary outcome
Percentage of participants who attend an HIV care visit within 30 days after enrollment
Time frame: Within 30 days after enrollment
Linkage to HIV care is defined as completion of at least one visit with a STRIVE telehealth navigator, within 30 days after enrollment. Visit attendance will be recorded as Yes or No documented by a STRIVE telehealth navigator. The outcome will be reported as the percentage of participants who meet this criterion.
Percentage of participants who are linked to HIV prevention within 30 days after enrollment
Time frame: Within 30 days after enrollment
Linkage to HIV prevention is defined as completion of at least one visit with a STRIVE telehealth navigator, within 30 days after enrollment. Visit attendance will be recorded as Yes or No documented by a STRIVE telehealth navigator. The outcome will be reported as the percentage of participants who meet this criterion.
3 secondary outcomes
Percentage of participants who are linked to mental health care
Time frame: Within 30 days after enrollment
brief Berger HIV Stigma scale
Time frame: Baseline, immediate post, 30 days post
Attitudes Toward Seeking Professional Psychological Help Scale-Short Form
Time frame: Baseline, immediately post, 30 days post
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Oct 2026.
- Individual participant dataSharing planned: Yes
Related trials for HIV
Recruiting
The Trans-Led Care Study
Substance Abuse, Substance Addiction
RecruitingObservational study
Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection
HIV
RecruitingObservational study
Olfactory Function and Model-Based Behavior in People Living With HIV and SUD
HIV, Substance Use Disorder
RecruitingPhase 1
AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study")
AIDS-Related Diffuse Large B-cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
RecruitingObservational study
Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants
HIV
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
A study testing Brief Videos for HIV Stigma in people with HIV and Mental Health, run by City University of New York, School of Public Health.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 1 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Philip Kreniske, PhD ((646) 364-9600, philip.kreniske@sph.cuny.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Percentage of participants who attend an HIV care visit within 30 days after enrollment (time frame: Within 30 days after enrollment). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Oct 2026.